USD 0.35
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2024 | 1.4 Million USD | -26.15% |
2023 | 1.89 Million USD | 19.89% |
2022 | 1.58 Million USD | 9.54% |
2021 | 1.44 Million USD | -11.07% |
2020 | 1.62 Million USD | 10.42% |
2019 | 1.47 Million USD | 2.47% |
2018 | 1.43 Million USD | 27.28% |
2017 | 1.12 Million USD | -34.74% |
2016 | 1.73 Million USD | -26.01% |
2015 | 2.33 Million USD | 5.12% |
2014 | 2.22 Million USD | -24.06% |
2013 | 2.92 Million USD | 17.68% |
2012 | 2.48 Million USD | -4.41% |
2011 | 2.6 Million USD | 5.12% |
2010 | 2.47 Million USD | -1.1% |
2009 | 2.5 Million USD | 10.29% |
2008 | 2.27 Million USD | 28.72% |
2007 | 1.76 Million USD | 26.12% |
2006 | 1.39 Million USD | 15.55% |
2005 | 1.21 Million USD | 14.21% |
2004 | 1.06 Million USD | 13.82% |
2003 | 931.32 Thousand USD | 8.7% |
2002 | 856.78 Thousand USD | 11.71% |
2001 | 766.99 Thousand USD | 29.01% |
2000 | 594.51 Thousand USD | 35.36% |
1999 | 439.21 Thousand USD | -19.11% |
1998 | 543 Thousand USD | 4.08% |
1997 | 521.69 Thousand USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 1.64 Million USD | -12.05% |
2024 Q1 | 1.86 Million USD | -1.69% |
2024 FY | 1.4 Million USD | -26.15% |
2024 Q3 | 1.55 Million USD | -5.35% |
2024 Q4 | 1.4 Million USD | -9.77% |
2023 Q3 | 1.9 Million USD | 2.56% |
2023 Q1 | 1.79 Million USD | 13.57% |
2023 FY | 1.89 Million USD | 19.89% |
2023 Q4 | 1.89 Million USD | -0.37% |
2023 Q2 | 1.85 Million USD | 3.31% |
2022 Q1 | 1.59 Million USD | 10.03% |
2022 Q2 | 1.52 Million USD | -4.4% |
2022 Q3 | 1.4 Million USD | -7.56% |
2022 Q4 | 1.58 Million USD | 12.66% |
2022 FY | 1.58 Million USD | 9.54% |
2021 FY | 1.44 Million USD | -11.07% |
2021 Q2 | 1.55 Million USD | -8.78% |
2021 Q1 | 1.7 Million USD | 5.04% |
2021 Q4 | 1.44 Million USD | -4.99% |
2021 Q3 | 1.52 Million USD | -2.31% |
2020 Q4 | 1.62 Million USD | 19.56% |
2020 Q2 | 1.34 Million USD | -2.54% |
2020 Q3 | 1.36 Million USD | 1.27% |
2020 FY | 1.62 Million USD | 10.42% |
2020 Q1 | 1.37 Million USD | -6.42% |
2019 Q4 | 1.47 Million USD | 5.86% |
2019 Q3 | 1.39 Million USD | 1.68% |
2019 Q1 | 1.23 Million USD | -13.99% |
2019 FY | 1.47 Million USD | 2.47% |
2019 Q2 | 1.36 Million USD | 10.68% |
2018 Q1 | 1.2 Million USD | 6.29% |
2018 Q3 | 1.24 Million USD | 2.72% |
2018 Q4 | 1.43 Million USD | 15.24% |
2018 FY | 1.43 Million USD | 27.28% |
2018 Q2 | 1.21 Million USD | 1.17% |
2017 Q2 | 1.45 Million USD | -14.74% |
2017 Q3 | 1.13 Million USD | -22.09% |
2017 FY | 1.12 Million USD | -34.74% |
2017 Q1 | 1.71 Million USD | -1.16% |
2017 Q4 | 1.12 Million USD | -0.62% |
2016 Q4 | 1.73 Million USD | -13.54% |
2016 FY | 1.73 Million USD | -26.01% |
2016 Q1 | 2.19 Million USD | -6.12% |
2016 Q2 | 1.97 Million USD | -10.07% |
2016 Q3 | 2 Million USD | 1.37% |
2015 Q4 | 2.33 Million USD | 11.97% |
2015 FY | 2.33 Million USD | 5.12% |
2015 Q2 | 2.11 Million USD | -2.04% |
2015 Q1 | 2.16 Million USD | -2.84% |
2015 Q3 | 2.08 Million USD | -1.37% |
2014 Q1 | 2.92 Million USD | -0.31% |
2014 FY | 2.22 Million USD | -24.06% |
2014 Q4 | 2.22 Million USD | -16.29% |
2014 Q3 | 2.65 Million USD | -4.8% |
2014 Q2 | 2.79 Million USD | -4.42% |
2013 Q4 | 2.92 Million USD | 11.71% |
2013 Q2 | 2.47 Million USD | 3.95% |
2013 Q1 | 2.37 Million USD | -4.46% |
2013 FY | 2.92 Million USD | 17.68% |
2013 Q3 | 2.62 Million USD | 6.07% |
2012 Q1 | 2.69 Million USD | 3.42% |
2012 Q4 | 2.48 Million USD | -7.02% |
2012 FY | 2.48 Million USD | -4.41% |
2012 Q2 | 2.68 Million USD | -0.17% |
2012 Q3 | 2.67 Million USD | -0.43% |
2011 Q4 | 2.6 Million USD | 5.17% |
2011 Q3 | 2.47 Million USD | -2.2% |
2011 FY | 2.6 Million USD | 5.12% |
2011 Q2 | 2.53 Million USD | -4.14% |
2011 Q1 | 2.64 Million USD | 6.62% |
2010 Q1 | 2.45 Million USD | -1.8% |
2010 Q3 | 2.35 Million USD | -3.15% |
2010 FY | 2.47 Million USD | -1.1% |
2010 Q2 | 2.42 Million USD | -1.29% |
2010 Q4 | 2.47 Million USD | 5.35% |
2009 Q2 | 1.94 Million USD | -5.09% |
2009 Q4 | 2.5 Million USD | 19.37% |
2009 Q3 | 2.09 Million USD | 7.83% |
2009 FY | 2.5 Million USD | 10.29% |
2009 Q1 | 2.05 Million USD | -9.73% |
2008 Q1 | 1.93 Million USD | 9.68% |
2008 FY | 2.27 Million USD | 28.72% |
2008 Q3 | 2.09 Million USD | 2.3% |
2008 Q4 | 2.27 Million USD | 8.57% |
2008 Q2 | 2.04 Million USD | 5.67% |
2007 FY | 1.76 Million USD | 26.12% |
2007 Q3 | 1.52 Million USD | 10.09% |
2007 Q1 | 1.29 Million USD | -7.74% |
2007 Q4 | 1.76 Million USD | 16.05% |
2007 Q2 | 1.38 Million USD | 7.0% |
2006 Q4 | 1.39 Million USD | -13.96% |
2006 Q1 | 1.36 Million USD | 12.8% |
2006 Q3 | 1.62 Million USD | 14.68% |
2006 Q2 | 1.41 Million USD | 3.82% |
2006 FY | 1.39 Million USD | 15.55% |
2005 FY | 1.21 Million USD | 14.21% |
2005 Q3 | 1.11 Million USD | 2.83% |
2005 Q1 | 1.12 Million USD | 6.48% |
2005 Q4 | 1.21 Million USD | 8.88% |
2005 Q2 | 1.08 Million USD | -4.2% |
2004 Q2 | 1.06 Million USD | -1.37% |
2004 FY | 1.06 Million USD | 13.82% |
2004 Q3 | 1.14 Million USD | 6.94% |
2004 Q4 | 1.06 Million USD | -7.35% |
2004 Q1 | 1.08 Million USD | 16.47% |
2003 Q2 | 797.81 Thousand USD | 0.0% |
2003 FY | 931.32 Thousand USD | 8.7% |
2003 Q4 | 931.32 Thousand USD | 1.08% |
2003 Q3 | 921.33 Thousand USD | 15.48% |
2003 Q1 | 797.79 Thousand USD | -6.88% |
2002 Q1 | 738.33 Thousand USD | -3.74% |
2002 Q2 | 934.55 Thousand USD | 26.58% |
2002 FY | 856.78 Thousand USD | 11.71% |
2002 Q4 | 856.78 Thousand USD | -19.6% |
2002 Q3 | 1.06 Million USD | 14.03% |
2001 Q3 | 760.16 Thousand USD | 3.5% |
2001 FY | 766.99 Thousand USD | 29.01% |
2001 Q2 | 734.42 Thousand USD | 6.57% |
2001 Q4 | 766.99 Thousand USD | 0.9% |
2001 Q1 | 689.15 Thousand USD | 15.92% |
2000 Q4 | 594.51 Thousand USD | 8.23% |
2000 Q3 | 549.28 Thousand USD | 0.0% |
2000 FY | 594.51 Thousand USD | 35.36% |
1999 FY | 439.21 Thousand USD | -19.11% |
1998 FY | 543 Thousand USD | 4.08% |
1997 FY | 521.69 Thousand USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
American Medical Technologies Inc. | 133.82 Thousand USD | -947.858% |
Ansell Limited | 457.04 Million USD | 99.693% |
Ansell Limited | 457.9 Million USD | 99.694% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 43.33 Million USD | 96.764% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 27.89 Thousand USD | -4928.103% |
Psykey, Inc. | 49.94 Thousand USD | -2708.046% |
ConvaTec Group Plc | 395.54 Million USD | 99.645% |
ConvaTec Group Plc | 396.1 Million USD | 99.646% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | -9294.00 USD | 15188.638% |
LifePoint, Inc. | 2.3 Million USD | 39.275% |
Medite Cancer Diagnostics, Inc. | 2.4 Million USD | 41.642% |
Paradigm Medical Industries, Inc. | 441 Thousand USD | -217.99% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 91.88 Thousand USD | -1426.238% |
Reflect Scientific, Inc. | 972.29 Thousand USD | -44.23% |
SmileDirectClub, Inc. | 49.87 Million USD | 97.188% |
Sector 10, Inc. | - USD | -Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | 99.601% |
SheerVision, Inc. | 339.66 Thousand USD | -312.862% |
United Health Products, Inc. | 33.59 Thousand USD | -4073.873% |
Vasamed, Inc. | 449.02 Thousand USD | -212.305% |
Wearable Health Solutions, Inc. | 8555.00 USD | -16292.028% |
Yubo International Biotech Limited | 322.17 Thousand USD | -335.275% |